Meeting
2016 Gastrointestinal Cancers Symposium
The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy.
Authors
Hung-Yang Kuo
Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu City, Taiwan
Hung-Yang Kuo , Jhe-Cyuan Guo , Ta-Chen Huang , Chia-Chi Lin , Min-Shu Hsieh , Jang-Ming Lee , Jason C. Cheng , Hsiu-Po Wang , Kun-Huei Yeh , Chih-Hung Hsu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 80)
DOI
10.1200/jco.2016.34.4_suppl.80
Abstract #
80
Poster Bd #
J14
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Recurrence patterns in esophageal cancer patients undergoing curative trimodality therapy.
First Author: Edwin Chan
Poster
2014 ASCO Annual Meeting
Cisplatin versus cetuximab plus concomitant radiotherapy in locally advanced head and neck cancer: A meta-analysis of published trials.
First Author: Sandro Barni
Poster
2024 ASCO Annual Meeting
Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial.
First Author: Manabu Muto
Poster
2023 ASCO Breakthrough
Impact of pathological response and recurrence pattern on the survival of patients who develop recurrence from neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma (ESCC).
First Author: Chien Huai Chuang